Pfizer and NovaMedica announce a strategic partnership in Russia

Pfizer Inc. (PFE) Ready to Reconnoiter Russian Therapeutic Markets

18 July 2016 Raheel Farooq / Business Finance News

As restrictions in the Western countries rise and growth remains stagnant, Pfizer has taken a wise step to slowly and steadily enter Russia with the establishment of a manufacturing unit. Pfizer Inc. is in the process to develop manufacturing facilities in numerous geographical territories around the globe. Recently, the drug maker signed its third mega deal in the past several years, which is an agreement with Russia’s NovaMedica to build a manufacturing unit.

Pfizer strikes second deal this year for drug production in Russia

18 July 2016 Eric Palmer / Fierce Pharma

Pfizer was a little behind some of its peers in establishing local manufacturing in Russia but it's on a roll now, having just announced its third deal in several years. It is hammering out an agreement with Russia’s NovaMedica for a new manufacturing plant. 

Pfizer's Russia Deal Shows Country Still Open To Western Business

15 July 2016 Kenneth Rapoza / Forbes

U.S. multinational drug maker Pfizer PFE +1.68% is laying down a new foundation in Russia, with a joint venture announced on Wednesday to produce pharmaceuticals domestically.

Pfizer links with NovaMedica to produce and market drugs in Russia

15 July 2016 The Pharma Letter

US pharma giant Pfizer (NYSE: PFE) and NovaMedica, a company established by Russian high-technology investment fund Rusnano and American venture health care fund Domain Associates in 2012, have entered into an agreement to cooperate, signalling the development of a new partnership, to bring important medicines to the Russian market.

Photo: Pfizer and NovaMedica announce a strategic partnership in Russia

13 July 2016

Pfizer, one of the world’s premier biopharmaceutical companies and NovaMedica, a Russian pharmaceutical company established by Rusnano and Domain Associates, have entered into an agreement to cooperate, signalling the development of a new partnership. Through this partnership, Pfizer proposes to invest in NovaMedica’s construction of a new manufacturing plant in the Kaluga region and license the technology for production of more than 30 medicinal products from its portfolio to the Russian partner.